{
  "id": "tumor_lysis_syndrome_bowtie_v1",
  "type": "bowtie",
  "stem": "A client with leukemia begins aggressive chemotherapy. At 1400, labs show Phosphorus 6.5 mg/dL, Calcium 7.0 mg/dL, and Uric Acid 12.0 mg/dL. Complete the bowtie to manage this oncologic emergency.",
  "actions": [
    {
      "id": "action4",
      "text": "Restrict fluid intake to prevent edema",
      "isCorrect": false,
      "rationale": "Fluid restriction is contraindicated in TLS. The goal is to flush the kidneys to prevent uric acid crystal formation and subsequent acute kidney injury. Restricting fluids will worsen hyperuricemia and increase the risk of renal damage."
    },
    {
      "id": "action1",
      "text": "Initiate aggressive IV hydration (3L/day)",
      "isCorrect": true,
      "rationale": "Aggressive IV hydration is crucial in TLS. It increases urine output, dilutes serum electrolyte concentrations, and promotes the excretion of potassium, phosphate, and uric acid, preventing acute kidney injury. A typical rate is 3L/day, but this should be adjusted based on the patient's cardiac and renal status."
    },
    {
      "id": "action3",
      "text": "Administer PO Phosphate supplements",
      "isCorrect": false,
      "rationale": "Phosphate levels are already elevated in TLS due to cell lysis. Administering phosphate supplements will exacerbate hyperphosphatemia, further decreasing calcium levels and increasing the risk of complications like cardiac arrhythmias and seizures."
    },
    {
      "id": "action2",
      "text": "Administer PO/IV Allopurinol or Rasburicase",
      "isCorrect": true,
      "rationale": "Allopurinol and Rasburicase are used to lower uric acid levels. Allopurinol inhibits xanthine oxidase, the enzyme responsible for uric acid production. Rasburicase is a recombinant urate oxidase that converts uric acid to allantoin, a more soluble compound that is easily excreted by the kidneys. Rapid reduction of uric acid prevents kidney damage."
    }
  ],
  "potentialConditions": [
    "Tumor Lysis Syndrome (TLS)",
    "DIC",
    "Acute Kidney Injury",
    "Hyperkalemia (Renal)"
  ],
  "condition": "Tumor Lysis Syndrome (TLS)",
  "parameters": [
    {
      "id": "param2",
      "text": "Urine Output and pH",
      "isCorrect": true,
      "rationale": "Monitoring urine output is essential to assess the effectiveness of IV hydration and kidney function. Maintaining a urine pH >7.0 helps prevent uric acid crystallization in the renal tubules. Alkalinizing the urine can be achieved with IV sodium bicarbonate. Decreased urine output indicates inadequate hydration or developing kidney injury."
    },
    {
      "id": "param4",
      "text": "Hemoglobin and Hematocrit",
      "isCorrect": false,
      "rationale": "While hemoglobin and hematocrit are important indicators of overall health, they are not the primary parameters to monitor in the acute management of TLS. They do not directly reflect the electrolyte imbalances or kidney dysfunction associated with TLS."
    },
    {
      "id": "param3",
      "text": "WBC count",
      "isCorrect": false,
      "rationale": "WBC count is not a priority parameter to monitor in the acute management of TLS. While the client has leukemia, the immediate concern is the metabolic derangements caused by cell lysis, not the WBC count itself."
    },
    {
      "id": "param1",
      "text": "Serum Electrolytes (K, Phos, Ca, Uric Acid)",
      "isCorrect": true,
      "rationale": "Frequent monitoring of serum electrolytes (potassium, phosphorus, calcium, and uric acid) is crucial in TLS. These electrolytes are directly affected by cell lysis, and their levels can fluctuate rapidly. Early detection of electrolyte imbalances allows for prompt intervention to prevent life-threatening complications such as cardiac arrhythmias (hyperkalemia, hypocalcemia), seizures (hypocalcemia), and acute kidney injury (hyperuricemia, hyperphosphatemia)."
    }
  ],
  "correctActionIds": [
    "action1",
    "action2"
  ],
  "correctParameterIds": [
    "param1",
    "param2"
  ],
  "pedagogy": {
    "bloomLevel": "analyze",
    "cjmmStep": "takeAction",
    "nclexCategory": "Physiological Adaptation",
    "difficulty": 5,
    "topicTags": [
      "Oncology",
      "Emergency",
      "TLS"
    ]
  },
  "rationale": {
    "correct": "TLS results from rapid cell death, releasing intracellular contents (high K+, high Phos, high Uric Acid, low Ca2+). The priority is to flush the kidneys with aggressive hydration and lower uric acid levels with Allopurinol/Rasburicase to prevent renal failure. Monitoring focuses on electrolytes and kidney function (urine output and pH).",
    "incorrect": "Phosphate supplements worsen hyperphosphatemia. Fluid restriction exacerbates uric acid crystal formation in the kidneys. WBC count is not the acute monitoring priority during TLS resolution. Hemoglobin and Hematocrit are not the most sensitive or specific parameter for evaluating this patient's status.",
    "clinicalPearls": [
      "Hyperkalemia leading to cardiac arrest and hyperuricemia causing acute kidney injury are the most dangerous aspects of TLS. Early recognition and aggressive management are critical. Consider continuous cardiac monitoring.",
      "Monitor for signs of hypocalcemia (e.g., muscle cramps, tetany, seizures) and hyperkalemia (e.g., peaked T waves, muscle weakness).",
      "Urine alkalinization with sodium bicarbonate can help prevent uric acid crystallization in the kidneys."
    ],
    "questionTrap": {
      "trap": "Calcium management",
      "howToOvercome": "Low calcium in TLS is usually caused by high phosphate. Correcting the phosphate imbalance typically resolves the hypocalcemia. Avoid administering calcium unless the patient is symptomatic (e.g., tetany, seizures) due to the risk of calcium phosphate precipitation in the kidneys."
    },
    "answerBreakdown": [
      {
        "label": "ðŸŽ¯ Condition",
        "content": "The condition \"Tumor Lysis Syndrome (TLS)\" is the only diagnosis that accounts for the constellation of clinical findings present.",
        "isCorrect": true
      },
      {
        "label": "âš¡ Action",
        "content": "\"Restrict fluid intake to prevent edema\" is inappropriate or secondary for a client experiencing this specific clinical crisis.",
        "isCorrect": false
      },
      {
        "label": "âš¡ Action",
        "content": "Implementing \"Initiate aggressive IV hydration (3L/day)\" directly targets the acute pathophysiology of the suspected condition.",
        "isCorrect": true
      },
      {
        "label": "âš¡ Action",
        "content": "\"Administer PO Phosphate supplements\" is inappropriate or secondary for a client experiencing this specific clinical crisis.",
        "isCorrect": false
      },
      {
        "label": "âš¡ Action",
        "content": "Implementing \"Administer PO/IV Allopurinol or Rasburicase\" directly targets the acute pathophysiology of the suspected condition.",
        "isCorrect": true
      },
      {
        "label": "ðŸ“Š Parameter",
        "content": "Monitoring \"Urine Output and pH\" provides high-fidelity data on the client's progress or clinical deterioration.",
        "isCorrect": true
      },
      {
        "label": "ðŸ“Š Parameter",
        "content": "\"Hemoglobin and Hematocrit\" is not the most sensitive or specific parameter for evaluating this patient's status.",
        "isCorrect": false
      },
      {
        "label": "ðŸ“Š Parameter",
        "content": "\"WBC count\" is not the most sensitive or specific parameter for evaluating this patient's status.",
        "isCorrect": false
      },
      {
        "label": "ðŸ“Š Parameter",
        "content": "Monitoring \"Serum Electrolytes (K, Phos, Ca, Uric Acid)\" provides high-fidelity data on the client's progress or clinical deterioration.",
        "isCorrect": true
      }
    ],
    "mnemonic": {
      "title": "TLS",
      "expansion": "T = Tumor\nL = Lysis\nS = Syndrome\n\nKey Actions: Initiate aggressive IV hydration (3L/day); Administer PO/IV Allopurinol or Rasburicase\nKey Monitoring: Serum Electrolytes (K, Phos, Ca, Uric Acid); Urine Output and pH"
    },
    "reviewUnits": [
      {
        "heading": "Tumor Lysis Syndrome â€” Pathophysiology & Recognition",
        "body": "TLS = Cell death spilling contents (high K, high Phos, high Uric Acid, low Ca). Priority is flushing the kidneys (Hydration) and lowering uric acid (Allopurinol/Rasburicase) to prevent renal failure. Monitoring Focus: Electrolytes and Kidney function (Urine). The most dangerous part of TLS is hyperkalemia causing cardiac arrest and high uric acid causing acute kidney injury.",
        "source": "NCLEX-RN Clinical Review 2026"
      },
      {
        "heading": "Testing Trap â€” Calcium management",
        "body": "Low calcium in TLS is usually caused by high phosphate. If you fix the phosphate, the calcium levels usually stabilize.",
        "source": "NCLEX Test Strategy Guide"
      },
      {
        "heading": "Priority Interventions for Tumor Lysis Syndrome",
        "body": "The priority nursing interventions are: Initiate aggressive IV hydration (3L/day); Administer PO/IV Allopurinol or Rasburicase. Monitor: Serum Electrolytes (K, Phos, Ca, Uric Acid); Urine Output and pH. Giving more phosphate will worsen the crisis. Restricting fluids causes uric acid crystals to clog the kidneys. WBC is not the acute monitoring priority during TLS resolution.",
        "source": "Evidence-Based Nursing Practice"
      }
    ]
  },
  "scoring": {
    "method": "polytomous",
    "maxPoints": 5
  },
  "isCorrect": true,
  "sentinelStatus": "healed_v2026_v11"
}